Trial intelligence / Profile preview

Pelitrexol in metastatic colorectal cancer

NCT00078468Phase 2Completed

Sponsor
Pfizer
Start
Dec 2003
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of pelitrexol in colorectal cancer (CRC), sponsored by Pfizer. Started Dec 2003; status: completed.

02

Drugs

pelitrexol
03

Conditions

colorectal cancer (CRC)

Beyond the preview

Go deeper on NCT00078468.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00078468.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call